Scarica l'app Stockscreener
0.7974
2.17%
-0.0177
Pre-mercato:
.80
0.0026
+0.33%
Precedente Chiudi:
$0.8151
Aprire:
$0.81
Volume 24 ore:
133.78K
Relative Volume:
0.47
Capitalizzazione di mercato:
$61.28M
Reddito:
$9.53M
Utile/perdita netta:
$-44.61M
Rapporto P/E:
-0.8763
EPS:
-0.91
Flusso di cassa netto:
$-38.32M
1 W Prestazione:
+5.98%
1M Prestazione:
+7.54%
6M Prestazione:
+0.81%
1 anno Prestazione:
-34.10%
Intervallo 1D:
$0.78
$0.8197
Intervallo di 1 settimana:
$0.72
$0.96
Portata 52W:
$0.5406
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
Nome
Cue Biopharma Inc
Settore
Industria
Telefono
617-949-2680
Indirizzo
40 GUEST STREET, BOSTON, MA
Confronta CUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.7974 | 62.64M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-13 | Iniziato | Jefferies | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2022-11-21 | Iniziato | Piper Sandler | Overweight |
| 2022-01-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-03 | Iniziato | Craig Hallum | Buy |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-04-09 | Iniziato | Stifel | Buy |
| 2020-01-28 | Iniziato | BTIG Research | Buy |
| 2020-01-22 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Cue Biopharma Inc Borsa (CUE) Ultime notizie
Is Cue Biopharma Inc. stock a top momentum play2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Will Cue Biopharma Inc. stock recover after recent dropStop Loss & AI Driven Price Forecasts - newser.com
Using portfolio simulators with Cue Biopharma Inc. includedSwing Trade & Reliable Intraday Trade Plans - newser.com
How Cue Biopharma Inc. (1UC) stock stacks up against competitorsQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Is Cue Biopharma Inc. reversing from oversold territory2025 Valuation Update & Advanced Technical Analysis Signals - newser.com
Analyzing net buyer seller activity in Cue Biopharma Inc.Weekly Trade Review & Accurate Intraday Trade Tips - newser.com
What dividend safety score for Cue Biopharma Inc. stockRecession Risk & Long-Term Safe Investment Plans - newser.com
Is Cue Biopharma Inc. (1UC) stock undervalued after correctionTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
What recovery options are there for Cue Biopharma Inc.Buy Signal & Momentum Based Trading Ideas - newser.com
Published on: 2025-10-12 06:58:11 - newser.com
What drives Cue Biopharma Inc stock priceValue Stock Picks & Low Cost Trading Ideas - earlytimes.in
Cue Biopharma stock adds to gains after Nobel Prize validates CUE-401 approach - Investing.com Nigeria
Is Cue Biopharma (NASDAQ:CUE) Using Debt In A Risky Way? - simplywall.st
Tick level data insight on Cue Biopharma Inc. volatility2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Is it time to cut losses on Cue Biopharma Inc.Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Cue Biopharma, Inc. (NASDAQ:CUE) Sees Significant Drop in Short Interest - MarketBeat
Will Cue Biopharma Inc. stock reach all time highs in 2025July 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Reversal indicators forming on Cue Biopharma Inc. stockAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Will breakout in Cue Biopharma Inc. lead to full recoveryVolume Spike & Daily Growth Stock Tips - newser.com
Developing predictive dashboards with Cue Biopharma Inc. dataMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Market reaction to Cue Biopharma Inc.’s recent news2025 Top Decliners & Daily Profit Focused Screening - newser.com
Cue Biopharma names Usman Azam as new CEO and president - The Pharma Letter
Building trade automation scripts for Cue Biopharma Inc.2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Cue Biopharma names Usman Azam as new CEO, shifts focus to autoimmune disease - Investing.com Nigeria
Cue Biopharma Appoints Usman “Oz” Azam, M.D., as CEO - citybiz
Cue Biopharma Appoints Usman Azam as New CEO - TipRanks
Cue Biopharma Inc Azioni (CUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):